2
Jun 2026
GLP-1 receptor agonist drugs, used for the treatment of diabetes, and more recently, weight loss, are associated with a significantly lower long term risk of knee replacement surgery as a result of osteoarthritis, finds an analysis of medical records data, published in the open access journal Regional Anesthesia & Pain Medicine.
2
Jun 2026
Removing ultra-processed foods from the Mean American Diet could reduce environmental impacts, but the benefits are largely offset when the 2025–2030 Dietary Guidelines for Americans are modeled with higher protein intake. The study found that higher-protein, animal-heavy diets increased greenhouse gas emissions, land use, and nitrogen fertilizer use compared with current diets, while plant-based protein scenarios produced substantially lower impacts.
2
Jun 2026
A new PET imaging approach that measures synaptic density in the spinal cord provides a quantitative way to assess the brain's functional wiring in patients with multiple sclerosis.
2
Jun 2026
Mayo Clinic and Microsoft today announced a strategic collaboration to develop and deploy a frontier AI model designed specifically for healthcare, making Mayo Clinic's knowledge, expertise and integrated model of care available to more people when and where they need it.
2
Jun 2026
A new end-to-end PET imaging approach for osteosarcoma can rapidly and reliably distinguish tumor tissue from normal tissue and accurately assess surgical margins in real time.
2
Jun 2026
Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease.
2
Jun 2026
A triple-targeted preclinical therapy combining daraxonrasib, afatinib, and SD36 drove durable pancreatic cancer regression by blocking KRAS/RAS, EGFR/HER2, and STAT3 signaling. The approach prevented treatment resistance across mouse and human tumor-derived models, but remains preclinical and requires more clinically suitable drug combinations before human testing.
2
Jun 2026
This Burden of Proof review found that alcohol consumption is associated with higher risks for several cancers, liver disease, pancreatitis, lower respiratory infections, tuberculosis, and atrial fibrillation. Although low-to-moderate drinking showed modest observational links with lower risks of type 2 diabetes, dementia, and some cardiovascular outcomes, the evidence was weaker and potentially biased.
2
Jun 2026
Researchers developed Passive Heart-Rate Monitoring, a deep-learning smartphone system that estimates heart rate and daily resting heart rate from eight-second facial videos captured during normal phone use. Validated on more than 160,000 videos, the system met accuracy targets across skin-tone groups, although usable measurement rates were lower in the darkest skin-tone group and clinical use still requires further testing.
2
Jun 2026
Women with abnormal mammograms often have to wait for weeks to find out whether they have breast cancer.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
